- Clinical trials are research studies that test whether new Parkinson's treatments are safe and effective; they are not a guaranteed treatment.
- Trials generally move through four phases, and later phases test in larger groups of people over longer periods.
- ClinicalTrials.gov is a public registry where you can search Parkinson's studies by location, status, and eligibility.
- Joining a trial is voluntary: informed consent explains the risks and benefits, and you can leave a study at any time.
- Most people continue their usual Parkinson's care while participating, and you should never stop current treatment to join without your neurologist's guidance.
If you or someone you love is living with Parkinson’s disease, you may have wondered whether a clinical trial could be worth exploring. Research studies are how today’s treatments were developed, and new ones are constantly being tested. But joining a trial is a significant decision, and it helps to understand what these studies are, how they are structured, and how to find one responsibly. This guide explains how clinical trials for Parkinson’s work, where to search for them, and the questions to raise with your care team before you enroll. It is general education, not medical advice.
What a clinical trial actually is
A clinical trial is a research study that tests a medical approach — a drug, a device, a surgical technique, an exercise program, or a way of diagnosing or monitoring disease — in people. As the Parkinson’s Foundation puts it, trials help researchers learn what is safe and what works. That framing matters: a trial is designed to answer a scientific question, not to deliver a proven therapy. Some participants may benefit, some may not, and the treatment being studied might turn out to be no better than existing options. Many of the medications people rely on today exist only because earlier volunteers took part in this kind of research.
Not all studies are the same. Interventional trials test a treatment, while observational studies simply follow people over time to understand how Parkinson’s progresses or how existing treatments perform. Some studies enroll people with Parkinson’s; others recruit healthy volunteers for comparison. Understanding which type you are considering is a good first step.
The four phases of a trial
Treatments generally move through a sequence of phases before regulators approve them, and the Parkinson’s Foundation notes that the FDA typically requires three phases before approval, with a possible fourth afterward. In broad terms:
| Phase | Main question it asks |
|---|---|
| Phase 1 | Is it safe, and what dose can people tolerate? Usually a small group. |
| Phase 2 | Does it appear to work, and what are the side effects? A larger group. |
| Phase 3 | How does it compare with standard treatment across a much larger group? |
| Phase 4 | How does it perform in the real world after approval, over the long term? |
Earlier-phase studies tend to carry more unknowns because less is known about the treatment. That does not make them wrong to join — it simply means the informed-consent conversation is especially important.
How to search ClinicalTrials.gov
The central resource is ClinicalTrials.gov, a public registry maintained by the U.S. National Library of Medicine that lists studies in the United States and around the world. You can search by condition (for example, “Parkinson’s disease”), then filter by your location, the study’s recruitment status (whether it is actively enrolling), and eligibility details. Each record describes the study’s purpose, its phase, who can participate, and how to contact the research team.
The Parkinson’s Foundation also maintains study-matching resources, and other reputable organizations run trial finders that match your location and health history to open studies. MedlinePlus, the NIH’s consumer health service, is another good starting point for understanding how studies are structured before you dive into individual listings. Whichever tool you use, legitimate trials are reviewed by an Institutional Review Board (IRB) — an independent committee that, as MedlinePlus explains, exists to protect participants’ rights and welfare and to weigh whether the risks are reasonable compared with the potential benefits. Legitimate trials also do not charge you to participate.
Informed consent and your right to withdraw
Before you join anything, the study team walks you through informed consent. This is a detailed explanation of what the study involves, what is expected of you, and the known risks and potential benefits. You are encouraged to ask questions and take your time deciding — there is no obligation to sign on the spot. Bring the consent document home, read it carefully, and discuss it with your family and your doctor.
Crucially, participation is always voluntary. As the Parkinson’s Foundation emphasizes, even if you choose to join, you can stop at any time, for any reason, without losing access to your regular medical care. Consent is not a contract that traps you; it is an agreement you can revisit.
Research is not a substitute for your usual care
One of the most important points to understand is that a trial does not replace your ongoing treatment. Most people continue their standard Parkinson’s care while participating. You should never stop or change your current medications in order to qualify for or join a study without your neurologist’s explicit guidance — abruptly altering Parkinson’s therapy can cause your symptoms to worsen. If a study requires a change to your regimen, that change should be planned and supervised, and your own doctor should be part of the conversation.
Your neurologist can help you weigh whether a particular trial fits your diagnosis, symptoms, and goals. They know your history, can flag potential conflicts with your current treatment, and can help you interpret the eligibility criteria. Coordinating care can be easier than it sounds; many movement-disorder specialists are reachable through telehealth for the kind of check-in that a trial decision warrants.
Questions worth asking before you enroll
- What is the purpose of this study, and which phase is it in?
- What treatments or procedures are involved, and what are the possible risks and side effects?
- Is there a placebo group, and what are my chances of receiving the active treatment?
- How long does the study last, how many visits are required, and where?
- Will I continue my usual medications, and who coordinates with my own doctor?
- What happens if my symptoms change or I want to leave the study?
- Are travel, time, or other costs covered?
Frequently asked questions
Will a clinical trial cure my Parkinson’s? No one can promise that. A trial tests whether an approach is safe and effective; the result is not known in advance, which is precisely why the research is being done.
Do I have to pay to join a trial? Legitimate trials do not charge you to participate. Some cover study-related costs and travel. Be cautious of any program that asks for payment to enroll.
Could I receive a placebo instead of the real treatment? Some trials include a placebo group to compare against. The consent process should explain whether this applies and what your chances are of receiving the active treatment.
Can I leave a study once I have started? Yes. Participation is voluntary, and you can withdraw at any time without affecting your regular medical care.
How do I find trials near me? Start with ClinicalTrials.gov and filter by location and recruitment status, and ask your neurologist or a Parkinson’s organization about studies they know of.
Should I stop my medications to qualify? Never do this on your own. Any change to your Parkinson’s treatment must be planned with your doctor.
This article is general education and is not medical advice. Talk to a qualified clinician about your situation.
For broader context on living with a movement disorder and coordinating specialist care, see our medical conditions guide.
Sources
- ClinicalTrials.gov — U.S. National Library of Medicine registry of clinical studies
- MedlinePlus (NIH) — clinical trials and Institutional Review Board protections
- Parkinson’s Foundation — clinical trials, phases, informed consent, and participation